Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.
de Boer, Pieter T
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. [electronic resource] - BMC medicine 12 2018 - 228 p. digital
Publication Type: Journal Article
1741-7015
10.1186/s12916-018-1213-5 doi
Adjuvants, Immunologic--economics
Aged
Aged, 80 and over
Cost-Benefit Analysis--methods
Female
Herpes Zoster--drug therapy
Herpes Zoster Vaccine--economics
Humans
Male
Middle Aged
Netherlands
Quality of Life
Vaccines, Attenuated--economics
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. [electronic resource] - BMC medicine 12 2018 - 228 p. digital
Publication Type: Journal Article
1741-7015
10.1186/s12916-018-1213-5 doi
Adjuvants, Immunologic--economics
Aged
Aged, 80 and over
Cost-Benefit Analysis--methods
Female
Herpes Zoster--drug therapy
Herpes Zoster Vaccine--economics
Humans
Male
Middle Aged
Netherlands
Quality of Life
Vaccines, Attenuated--economics